I would not want you to stop posting either. I like quite a few others have a fair bit of skin in BRM. You seem keen to explore the BRM-FRS option. FRS needs this more than BRM.
I take Bones as implying that it is WN Associates transferring their shares to WN, and not existing proper BRM investors. If you are right then Bones' email implies a major turnaround. However I do not think that is the case. If it is otherwise perhaps Bones can expand on his summary. Also I recall, pre-WN Takover days retail shareholders represented the largest segment by a large degree.
BRM Price at posting:
$4.85 Sentiment: LT Buy Disclosure: Held